Passage Bio, Inc. (PASG) Tops Q2 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
Tweet
Share
E-mailGet Alerts PASG Hot Sheet
Join SI Premium – FREE
Passage Bio, Inc. (NASDAQ: PASG) reported Q2 EPS of ($0.26), $0.05 better than the analyst estimate of ($0.31).
For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cleveland-Cliffs (CLF) Tops Q3 EPS by 6c
- Goldman Sachs Upgrades Nichicon Corp (T:6996) (NCHNF) to Buy
- Perfect Corp. shareholders approve go-private merger deal
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
